Chimerix, Inc. (CMRX) in Focus: Stock Up 5.6%

Chimerix, Inc. CMRX was a big mover last session, as the company saw its shares rise nearly 6% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock is now up 30.1% in the past one-month time frame.

The company has seen no estimate revisions in the past one month, while its Zacks Consensus Estimate of a loss narrowed over the same timeframe, suggesting that more solid trading could be ahead for the company. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Chimerix Corp currently has a Zacks Rank #4 (Sell) while its Earnings ESP is negative.

Other better-ranked players in the same industry include ICU Medical, Inc. ICUI with a Zacks Rank #1 (Buy) along with Abaxis, Inc. ABAX and Eagle Pharmaceuticals Inc. EGRX carrying a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CHIMERIX INC CMRX: Free Stock Analysis Report

ICU MEDICAL INC ICUI: Free Stock Analysis Report

ABAXIS INC ABAX: Free Stock Analysis Report

EAGLE PHARMACT EGRX: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments